SELLAS Life Sciences Group Inc. Common Stock vs Semtech Corporation Common Stock — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.65 (market cap $2.27B), while Semtech Corporation Common Stock trades at $187.3 (market cap $17.49B). The key difference: Semtech Corporation Common Stock is far larger — about 7.7× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Semtech Corporation Common Stock is trading nearer its 52-week high, SELLAS Life Sciences Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals.
| SLS | SMTC | |
|---|---|---|
Market Cap | $2.27B | $17.49B |
Volume | 4,179,659 | 4,235,937 |
Sector | Health | Technology |
52-Week High | $15.46 | $197.20 |
52-Week Low | $1.39 | $62.57 |
Enterprise Value | $2.14B | $17.78B |
Typical Hold Time | — | 1 Days |
Trailing returns across standard periods
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →Semtech develops analog and mixed-signal semiconductors and connectivity products. Its technologies are used in communications, data centers, industrial systems, and IoT devices.
Read more on SMTC →